Xiangyu Medical Co. Ltd. A

688626 · SHG · Healthcare / Medical Devices

41.40CNY-1.03 (-2.43%)

Price History

Full chart

Market Stats

Previous Close42.43

Open42.63

Day Range41.15 – 43.27

52-Week Range36.42 – 94.65

Volume2.40M

Market Cap6.71B

P/E (TTM)77.69

Forward P/E0.00

EPS0.54

Dividend Yield0.43%

Beta0.42

50-Day Avg42.32

200-Day Avg55.51

About

Xiangyu Medical Co.,Ltd engages in the research, development, manufacture, and marketing of rehabilitation, physiotherapy, and pain management equipment in China. It provides various therapy devices, such as smart occupational therapy, electrotherapy, sports therapy, rehabilitation, cold and heat therapy, gait, hydrotherapy, air compression therapy, phototherapy, traction tables, magnetic therapy, continuous passive motion (CPM), shock wave and ultrasound therapy, massage therapy, treatment tables and tilt tables, and microwave and shortwave therapy devices. The company was incorporated in 2002 and is headquartered in Anyang, China.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMr. Yongzheng He
Employees2.15K
HeadquartersMiddle Section of Diku Road, Anyang, China, 456300, China
Websitehttps://www.xyyl.com

Leadership

Mr. Yongzheng HeChairman, GM & Technical Director · b. 1972
Mr. Hongfeng JinFinancial Director · b. 1974
Mr. Zhang JieHead of Embedded Software of R&D Center · b. 1985
Mr. Ke ZhouHead of Scenario Simulation · b. 1980
Mr. Fan DuanHead of the Big Data Platform · b. 1978
Ms. Junling GuoDeputy GM, Director & Board Secretary · b. 1973

Financials

Income Statement

Currency: CNY	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	289.14M	358.86M	427.41M	495.51M	523.50M	488.53M	744.81M	743.53M	767.75M
Growth (%)	-	+24.11%	+19.10%	+15.93%	+5.65%	-6.68%	+52.46%	-0.17%	+3.26%
Cost of Revenue	119.47M	132.40M	148.24M	162.69M	169.57M	170.08M	243.35M	252.61M	256.21M
Gross Profit	169.67M	226.46M	279.18M	332.82M	353.92M	318.44M	501.46M	490.92M	767.75M
Gross Margin	58.68%	63.11%	65.32%	67.17%	67.61%	65.18%	67.33%	66.03%	100.00%
Operating Expense	92.13M	132.53M	132.03M	109.47M	129.86M	182.98M	256.83M	382.41M	690.68M
Operating Income	77.53M	93.92M	147.15M	223.35M	224.06M	135.46M	244.63M	108.51M	77.07M
Operating Margin	26.82%	26.17%	34.43%	45.07%	42.80%	27.73%	32.84%	14.59%	10.04%
EBITDA	84.12M	102.94M	157.14M	233.88M	234.15M	149.59M	267.69M	149.21M	110.87M
EBITDA Margin	29.09%	28.69%	36.76%	47.20%	44.73%	30.62%	35.94%	20.07%	14.44%
Net Income	64.47M	80.33M	128.98M	196.26M	201.90M	125.47M	227.14M	102.94M	78.70M
Net Income Margin	22.30%	22.38%	30.18%	39.61%	38.57%	25.68%	30.50%	13.85%	10.25%
R&D	17.42M	28.82M	41.49M	51.55M	68.61M	92.41M	106.75M	152.02M	175.06M
R&D as % of Total Revenue	6.02%	8.03%	9.71%	10.40%	13.11%	18.92%	14.33%	20.45%	22.80%
Interest Expense	493.56K	118.64K	150.62K	319.45K	61.79K	536.63K	6.25M	5.89M	5.70M
Interest Expense % of Total Revenue	0.17%	0.03%	0.04%	0.06%	0.01%	0.11%	0.84%	0.79%	0.74%

Balance Sheet

Currency: CNY	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	401.67M	561.49M	724.07M	981.53M	2.18B	2.37B	2.59B	2.93B	3.27B
Total Liabilities	302.59M	146.68M	176.79M	238.25M	236.97M	428.22M	484.69M	873.10M	-2.04B
Total Equity	99.09M	414.81M	547.26M	743.52M	1.94B	1.93B	2.09B	2.04B	2.04B
Cash	18.85M	19.67M	364.29M	487.24M	829.62M	726.31M	663.78M	743.18M	722.46M
Total Debt	10.00M	-	2.29M	50.00M	3.03M	17.15M	35.46M	365.23M	-
Net Debt	-8.85M	-19.67M	-362.00M	-437.24M	-826.58M	-709.16M	-628.33M	-377.95M	-

Cash Flow

Currency: CNY	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	59.31M	74.20M	155.94M	216.40M	165.88M	186.70M	227.91M	178.59M	189.82M
Investing Cash Flow	-117.80M	-136.73M	189.13M	-139.41M	-782.04M	-178.90M	-234.54M	-275.76M	-
Financing Cash Flow	56.37M	63.34M	-2.69M	48.19M	955.13M	-117.04M	-58.50M	148.38M	-
Capital Expenditure	14.84M	7.02M	21.07M	139.71M	133.91M	203.07M	479.26M	438.89M	287.18M
Free Cash Flow	44.47M	67.18M	134.88M	76.69M	31.97M	-16.37M	-251.35M	-260.30M	-97.37M
Dividends Paid	101.05M	34.44K	-	805.76K	59.20M	59.94M	40.46M	85.59M	44.43M
FCF to OCF	74.97%	90.54%	86.49%	35.44%	19.27%	-8.77%	-110.29%	-145.75%	-51.29%
Dividend Paid to FCF	227.24%	0.05%	-	1.05%	185.17%	-366.12%	-16.10%	-32.88%	-45.64%

Earnings

Report Date	Aug 24, 2021	Oct 29, 2021	Feb 22, 2022	Apr 27, 2022	Aug 19, 2022	Oct 28, 2022	Feb 10, 2023	Apr 27, 2023	Aug 6, 2023
EPS Estimate	-	-	-	-	-	-	-	-	-
EPS Actual	0.39	0.28	0.49	0.06	0.19	0.33	0.21	0.24	0.44
Surprise	-	-	-	-	-	-	-	-	-
Timing	Pre-market	After-hours	After-hours	Pre-market	After-hours	Pre-market	Pre-market	After-hours	Pre-market

Key Statistics & Ratios

Market Cap6.71B

Enterprise Value6.75B

Trailing P/E77.69

Forward P/E0.00

Price / Sales8.58

Price / Book3.37

EPS0.54

Book Value13.46

Revenue (TTM)781.87M

Gross Profit (TTM)508.12M

EBITDA89.38M

Profit Margin10.54%

Operating Margin0.82%

Return on Equity3.99%

Return on Assets0.72%

Shares Outstanding160.00M

Shares Float50.75M

Beta0.42

Dividend Yield0.43%

Dividend Rate0.18

Payout Ratio33.33%

Dividends

20261×

0.18Jun 17, 2026

20251×

0.24Jun 11, 2025

20241×

0.53Jun 28, 2024

20231×

0.24Jun 28, 2023

20221×

0.38Jun 27, 2022

20211×

0.37Jun 7, 2021